Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Heparan sulfate versus defibrotide for chronic venous insufficiency
2008-005612-40Phase 4Completed
- Sponsor
- Farmaceutici Damor
- Start
- Dec 2008
- Modality
- Vaccine mRNA → mRNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Chemically Modified siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Conjugated siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in venous stasis comparing Heparan sulfate with Defibrotide (2 arms). Primary endpoints: Therapeutic success and Relief of summed subjective symptom score. Started Dec 2008; status: completed.
02
Drugs
heparan sulfatedefibrotide
03
Conditions
venous stasis
Beyond the preview
Go deeper on 2008-005612-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005612-40.